Morgan Stanley has increased its investment rating on insurer Marsh & McLennan. From “equal weight” to “overweight.”
An analyst reported that the company’s stock price decline has been overdone given Marsh & McLennan’s variety of earnings mix, which includes profits from its fast-growing insurance brokerage segment.
According to the analyst, MMC is expected to generate $1.3 billion for free cash flow during the year.
Was this article valuable?
Here are more articles you may enjoy.
Man Admits to Tracking Drivers, Programming Keys, Stealing and Reselling Vehicles 
Hard Market Conditions Expected to Ease in 2025 as Claims Inflation Softens: Swiss Re 
Surplus Lines Commercial Growth; Fla. Litigation Costs Reach New High in 2023 
FM Global Rebrands As FM 
